Ascend Medical review
Two package prices are published and neither states what period they cover.
The verdict
Ascend Medical publishes a Starting Package at $225 for semaglutide and $240 for tirzepatide, read August 2026. Neither states a period. Not per month, not per supply. Neither figure is ranked here.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- States
- 2
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Ascend Medical sells both molecules by injection. Two packages carry a figure. Coverage is recorded in two states.
Who writes the prescription, and what do they see?
A prescription precedes dispensing. The pages name packages rather than clinicians. The intake is not documented. Nor is the duration of what is being sold.
A package price without a period is not comparable to anything. Two sellers quoting $225 are quoting different products if one covers four weeks and the other twelve. Ascend does not say which it is.
What happens when the dose goes up?
Nothing is published about dose. That question sits underneath the first one. Neither the duration nor the dose is stated. A package like that cannot be priced per milligram or per month.
What the price includes
No figure here can be turned into a monthly cost. $225 might be a month, a supply, or a starting block. The pages do not say. Ask before ordering, and get the answer in writing. Until then, treat both numbers as quotes rather than prices.
What it claims, and what it cites
Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: Two packages carry a published figure
- Strength: Both molecules are offered
- Strength: The word Starting is at least stated
- Limitation: No billing period appears anywhere
- Limitation: Neither figure can be compared
- Limitation: Coverage is recorded in two states
- Limitation: No dose information is published
What the evidence says about this kind of treatment
The assessment above is about Ascend Medical. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader prepared to ask what period the package covers before ordering.
- Wrong for
- A reader who needs a monthly figure to compare against another seller.
How Ascend Medical compares
| Seller | Who it suits | Go |
|---|---|---|
 CeliaRx | Readers who prefer a one-time purchase to a subscription and can fund it at once | See CeliaRx → |
More GLP-1 telehealth sellers reviews: Go Vida PlenaGobyMedsGoldspan HealthGood Girl RxGood Life MedsGreen Cap Health
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Is $225 a monthly price?
- Unknown. Ascend states no period beside either figure — not per month, not per supply.
- Why is nothing ranked here?
- A price with no period cannot be compared. Ranking it would put a number on a board that means something different from every other number on it.
- Where does Ascend operate?
- Coverage is recorded in two states.